{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:48:47Z","timestamp":1782805727277,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11060-026-05612-5","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:23:32Z","timestamp":1781018612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival after hypofractionated radiation versus standard radiation in glioblastoma by MGMT promoter methylation status and age: an analysis of the national cancer database"],"prefix":"10.1007","volume":"178","author":[{"given":"Megan","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Calixto-Hope G.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karisa C.","family":"Schreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin J.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence R.","family":"Kleinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordina","family":"Rincon-Torroella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"5612_CR1","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","volume":"26","author":"M Price","year":"2024","unstructured":"Price M, Ballard C, Benedetti J et al (2024) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017\u20132021. Neuro Oncol 26:vi1\u2013vi85. https:\/\/doi.org\/10.1093\/neuonc\/noae145","journal-title":"Neuro Oncol"},{"key":"5612_CR2","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A et al (2017) Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA 318:2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718","journal-title":"JAMA"},{"key":"5612_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5612_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/cncr.29742","volume":"122","author":"JT Jordan","year":"2016","unstructured":"Jordan JT, Gerstner ER, Batchelor TT et al (2016) Glioblastoma care in the elderly. Cancer 122:189\u2013197. https:\/\/doi.org\/10.1002\/cncr.29742","journal-title":"Cancer"},{"key":"5612_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","volume":"22","author":"W Roa","year":"2004","unstructured":"Roa W, Brasher PMA, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583\u20131588. https:\/\/doi.org\/10.1200\/JCO.2004.06.082","journal-title":"J Clin Oncol"},{"key":"5612_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ijrobp.2015.01.017","volume":"92","author":"ND Arvold","year":"2015","unstructured":"Arvold ND, Tanguturi SK, Aizer AA et al (2015) Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients. Int J Radiat Oncol Biol Phys 92:384\u2013389. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5612_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13014-015-0396-6","volume":"10","author":"M Azoulay","year":"2015","unstructured":"Azoulay M, Santos F, Souhami L et al (2015) Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution. Radiat Oncol 10:106. https:\/\/doi.org\/10.1186\/s13014-015-0396-6","journal-title":"Radiat Oncol"},{"key":"5612_CR8","first-page":"iv80","volume":"18","author":"P Navarria","year":"2016","unstructured":"Navarria P, Ascolese A, Cozzi L et al (2016) Randomized double arm phase III study to evaluate feasibility and safety of gamma knife radiosurgery versus linac based (edge) radiosurgery in brain metastatic patients. Neurooncology 18:iv80","journal-title":"Neurooncology"},{"key":"5612_CR9","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"376","author":"JR Perry","year":"2017","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ et al (2017) Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. N Engl J Med 376:1027\u20131037. https:\/\/doi.org\/10.1056\/NEJMoa1611977","journal-title":"N Engl J Med"},{"key":"5612_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ana.21521","volume":"64","author":"FM Iwamoto","year":"2008","unstructured":"Iwamoto FM, Reiner AS, Panageas KS et al (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64:628\u2013634. https:\/\/doi.org\/10.1002\/ana.21521","journal-title":"Ann Neurol"},{"key":"5612_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z","journal-title":"Nat Rev Clin Oncol"},{"key":"5612_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1200\/JCO-25-00250","volume":"43","author":"J Blakeley","year":"2025","unstructured":"Blakeley J, Mohile NA, Messersmith H et al (2025) Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update. J Clin Oncol 43:2129\u20132133. https:\/\/doi.org\/10.1200\/JCO-25-00250","journal-title":"J Clin Oncol"},{"key":"5612_CR13","unstructured":"National Comprehensive Cancer Network\u00ae (2025) NCCN Clinical Practice Guidelines in Oncology. NCCN Guidelines\u00ae) Central Nervous System Cancers"},{"key":"5612_CR14","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1093\/neuonc\/noaf177","volume":"27","author":"PY Wen","year":"2025","unstructured":"Wen PY, Weller M, Lee EQ et al (2025) Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 27:2751\u20132788. https:\/\/doi.org\/10.1093\/neuonc\/noaf177","journal-title":"Neuro Oncol"},{"key":"5612_CR15","doi-asserted-by":"publisher","first-page":"e0257384","DOI":"10.1371\/journal.pone.0257384","volume":"16","author":"SM de Melo","year":"2021","unstructured":"de Melo SM, Marta GN, Latorraca C, de OC et al (2021) Hypofractionated radiotherapy for newly diagnosed elderly glioblastoma patients: A systematic review and network meta-analysis. PLoS ONE 16:e0257384. https:\/\/doi.org\/10.1371\/journal.pone.0257384","journal-title":"PLoS ONE"},{"key":"5612_CR16","doi-asserted-by":"publisher","first-page":"100761","DOI":"10.1016\/j.ctro.2024.100761","volume":"46","author":"NK Mazarakis","year":"2024","unstructured":"Mazarakis NK, Robinson SD, Sinha P et al (2024) Management of glioblastoma in elderly patients: A review of the literature. Clin Transl Radiat Oncol 46:100761. https:\/\/doi.org\/10.1016\/j.ctro.2024.100761","journal-title":"Clin Transl Radiat Oncol"},{"key":"5612_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/cam4.1070","volume":"6","author":"KS Mak","year":"2017","unstructured":"Mak KS, Agarwal A, Qureshi MM, Truong MT (2017) Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database. Cancer Med 6:1192\u20131200. https:\/\/doi.org\/10.1002\/cam4.1070","journal-title":"Cancer Med"},{"key":"5612_CR18","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K et al (2017) Using the National Cancer Database for Outcomes Research: A Review. JAMA Oncol 3:1722\u20131728. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6905","journal-title":"JAMA Oncol"},{"key":"5612_CR19","unstructured":"Participant User Files (2025) In: ACS. https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-cancer-database\/puf\/. Accessed 3 Mar"},{"key":"5612_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573\u2013577. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010","journal-title":"Ann Intern Med"},{"key":"5612_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijrobp.2011.06.1992","volume":"83","author":"G Minniti","year":"2012","unstructured":"Minniti G, Lanzetta G, Scaringi C et al (2012) Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 83:93\u201399. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.06.1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5612_CR22","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa065901","volume":"356","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527\u20131535. https:\/\/doi.org\/10.1056\/NEJMoa065901","journal-title":"N Engl J Med"},{"key":"5612_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"5612_CR24","doi-asserted-by":"publisher","first-page":"e2523053","DOI":"10.1001\/jamanetworkopen.2025.23053","volume":"8","author":"L Zhong","year":"2025","unstructured":"Zhong L, Zhou P, Chen L et al (2025) Modified Target Delineation and Moderately Hypofractionated Radiotherapy for High-Grade Glioma: A Randomized Clinical Trial. JAMA Netw Open 8:e2523053. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.23053","journal-title":"JAMA Netw Open"},{"key":"5612_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/nop\/npae004","volume":"11","author":"TH Beckham","year":"2024","unstructured":"Beckham TH, Rooney MK, McAleer MF et al (2024) Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches. Neurooncol Pract 11:266\u2013274. https:\/\/doi.org\/10.1093\/nop\/npae004","journal-title":"Neurooncol Pract"},{"key":"5612_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0360-3016(97)00222-8","volume":"38","author":"L Kleinberg","year":"1997","unstructured":"Kleinberg L, Slick T, Enger C et al (1997) Short course radiotherapy is an appropriate option for most malignant glioma patients. Int J Radiat Oncol Biol Phys 38:31\u201336. https:\/\/doi.org\/10.1016\/s0360-3016(97)00222-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5612_CR27","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","volume":"13","author":"A Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m A, Gr\u00f8nberg BH, Marosi C et al (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916\u2013926. https:\/\/doi.org\/10.1016\/S1470-2045(12)70265-6","journal-title":"Lancet Oncol"},{"key":"5612_CR28","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","volume":"76","author":"YR Lawrence","year":"2010","unstructured":"Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20\u201327. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.02.091","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5612_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijrobp.2023.07.040","volume":"118","author":"R Upadhyay","year":"2024","unstructured":"Upadhyay R, Ayan AS, Jain S et al (2024) Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis. Int J Radiat Oncol Biol Phys 118:275\u2013284. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5612_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0360-3016(97)00580-4","volume":"40","author":"AW Lee","year":"1998","unstructured":"Lee AW, Foo W, Chappell R et al (1998) Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40:35\u201342. https:\/\/doi.org\/10.1016\/s0360-3016(97)00580-4","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5612_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"key":"5612_CR32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/neuonc\/noab105","volume":"23","author":"S Brandner","year":"2021","unstructured":"Brandner S, McAleenan A, Kelly C et al (2021) MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neurooncology 23:1457\u20131469. https:\/\/doi.org\/10.1093\/neuonc\/noab105","journal-title":"Neurooncology"},{"key":"5612_CR33","doi-asserted-by":"publisher","first-page":"vdab171","DOI":"10.1093\/noajnl\/vdab171","volume":"3","author":"MTC Poon","year":"2021","unstructured":"Poon MTC, Keni S, Vimalan V et al (2021) Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study. Neuro-Oncology Adv 3:vdab171. https:\/\/doi.org\/10.1093\/noajnl\/vdab171","journal-title":"Neuro-Oncology Adv"},{"key":"5612_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/brainsci13020216","volume":"13","author":"L Bonosi","year":"2023","unstructured":"Bonosi L, Marrone S, Benigno UE et al (2023) Maximal Safe Resection in Glioblastoma Surgery: A Systematic Review of Advanced Intraoperative Image-Guided Techniques. Brain Sci 13:216. https:\/\/doi.org\/10.3390\/brainsci13020216","journal-title":"Brain Sci"},{"key":"5612_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.wneu.2024.02.128","volume":"185","author":"C Apra","year":"2024","unstructured":"Apra C, Bemora JS, Palfi S (2024) Achieving Gross Total Resection in Neurosurgery: A Review of Intraoperative Techniques and Their Influence on Surgical Goals. World Neurosurg 185:246\u2013253. https:\/\/doi.org\/10.1016\/j.wneu.2024.02.128","journal-title":"World Neurosurg"},{"key":"5612_CR36","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/j.prro.2024.04.010","volume":"14","author":"S Booth","year":"2024","unstructured":"Booth S, Freeman JQ, Li JL, Huo D (2024) Increase in Hypofractionated Radiation Therapy Among Patients with Invasive Breast Cancer or Ductal Carcinoma In Situ: Who is Left Behind? Pract Radiat Oncol 14:e305\u2013e323. https:\/\/doi.org\/10.1016\/j.prro.2024.04.010","journal-title":"Pract Radiat Oncol"},{"key":"5612_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/archsurg.2009.288","volume":"145","author":"D Mukherjee","year":"2010","unstructured":"Mukherjee D, Zaidi HA, Kosztowski T et al (2010) Disparities in access to neuro-oncologic care in the United States. Arch Surg 145:247\u2013253. https:\/\/doi.org\/10.1001\/archsurg.2009.288","journal-title":"Arch Surg"},{"key":"5612_CR38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00432-014-1907-9","volume":"141","author":"G Ening","year":"2015","unstructured":"Ening G, Osterheld F, Capper D et al (2015) Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification. J Cancer Res Clin Oncol 141:1131\u20131137. https:\/\/doi.org\/10.1007\/s00432-014-1907-9","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05612-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05612-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05612-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:39:36Z","timestamp":1782805176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05612-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5612"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05612-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at Johns Hopkins University, with informed consent waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Information consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}